MARKERS AND METHODS FOR PRENATAL SCREENING OF CHROMOSOMAL ABERRATIONS

摘要

The invention concerns prenatal screening of chromosomal aberrations, more particularly, through identification of novel markers of chromosomal aberrations, in particular, trisomy 21, whereof the assay based on a body fluid of the pregnant woman enables, alone or in combination with other assays, the probability that the fetus suffers from a chromosomal aberration to be more accurately determined than that by currently used tests.